Articles

Find an Article

Filter articles

Showing 771 to 780 of 780 results

Recognising equivalence, reciprocity and respect

Canada, Mexico, US01-05-2011Hedwig Lindner and Manuel Morante

Homologation (recognition of equivalence) is a useful tool for simplifying administrative processes that are repeated in different countries. Nevertheless, it is not an end in itself.

Banning the patenting of biological materials in Australia: fact v fiction

Australia01-05-2011Tania Obranovich

An Australian legislative bill could have grave consequences for the country’s life sciences industry and, potentially, for patients as well. Tania Obranovich explains.

Windows of opportunity and closing doors at the EPO

EU01-05-2011Claire Baldock

There is a general acceptance that European patent law is complicated, particularly in the area of pharmaceutical inventions. Claire Baldock looks at how the EPO approaches these inventions.

Patenting life

EU01-05-2011Ashley Roughton

A case before the Court of Justice for the European Union threatens to radically redraw the patent landscape for embryonic stem cells. Ashley Roughton explains.

Myriad issues for gene patents

US01-05-2010

A recent US district court ruling could significantly affect companies that patent genes and threaten the health of an entire industry. LSIPR investigates.

What next for stem cell research?

EU01-05-2010

The European Court of Justice is faced with a crucial decision on stem cell research. Justin Turner QC explains.

New rules for French patents

France01-05-2010Stéphane Agasse

Following the implementation of EU Directive 2004/48/EC on the enforcement of IP rights under French patent law in 2007 and the publication of the corresponding implementing rules in 2008, the criteria adopted by the French courts to grant preliminary injunctions have also changed.

The risk of narrow protection

EU01-05-2010Caroline Pallard

A growing number of biotechnology inventions relate to peptides, oligonucleotides and other small molecules that could be used in therapeutic applications. Caroline Pallard explains the challenges of patenting such inventions.

Stricter examination requirements in Canada

Canada01-05-2010Katie Wang

Two pharmaceutical cases highlight recent developments in Canadian patent law relating to duty of candour during patent prosecution and patent claim construction, says Katie Wang.

Product definition in Swedish SPCs

Sweden01-05-2010Hampus Rystedt

There is a contradiction at the heart of product definition in Swedish supplementary protection certificates, says Hampus Rystedt.

Showing 771 to 780 of 780 results

LSIPR